Tag: Hoffmann la roche

At its peak in 1978, the anti-anxiety drug Valium (diazepam) sold 2.3 billion tablets in the United States, making it overwhelmingly clear **what was the top selling prescription drug in the 1970s**. This dominance reflected a broader cultural embrace of pharmaceuticals to manage anxiety, a trend that would later face significant backlash.

In 2009, pharmaceutical giant Hoffmann-La Roche announced it was ceasing production of the brand-name drug Accutane for the U.S. market. While many assume the move was a direct result of safety concerns, the reasons **why was Accutane discontinued in the US** are a complex mix of business decisions and mounting legal challenges, rather than an FDA-mandated recall.